InvestorsObserver is giving Homology Medicines Inc (FIXX) an Analyst Rating Rank of 5, meaning FIXX is ranked higher by analysts than 5% of stocks. The average price target for FIXX is $4.25 and analyst’s rate the stock as a Hold.
Wall Street analysts are rating FIXX a Hold today. Find out what this means to you and get the rest of the rankings on FIXX!